KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Goodwill (2016 - 2025)

Opko Health's Goodwill history spans 16 years, with the latest figure at $484.3 million for Q4 2025.

  • For Q4 2025, Goodwill fell 8.5% year-over-year to $484.3 million; the TTM value through Dec 2025 reached $484.3 million, down 8.5%, while the annual FY2025 figure was $484.3 million, 8.5% down from the prior year.
  • Goodwill reached $484.3 million in Q4 2025 per OPK's latest filing, roughly flat from $484.0 million in the prior quarter.
  • In the past five years, Goodwill ranged from a high of $710.4 million in Q4 2021 to a low of $476.7 million in Q1 2025.
  • Average Goodwill over 5 years is $572.4 million, with a median of $576.2 million recorded in 2022.
  • Peak YoY movement for Goodwill: dropped 23.23% in 2022, then rose 15.08% in 2023.
  • A 5-year view of Goodwill shows it stood at $710.4 million in 2021, then dropped by 16.13% to $595.9 million in 2022, then increased by 0.41% to $598.3 million in 2023, then dropped by 11.53% to $529.3 million in 2024, then dropped by 8.5% to $484.3 million in 2025.
  • Per Business Quant, the three most recent readings for OPK's Goodwill are $484.3 million (Q4 2025), $484.0 million (Q3 2025), and $484.2 million (Q2 2025).